Compton Capital Management Inc Kodiak Sciences Inc. Transaction History

Compton Capital Management Inc

  • $4.32 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$80.85 - $128.49 $177,870 - $282,678
-2,200 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$77.2 - $126.54 $15,440 - $25,308
200 Added 10.0%
2,200 $205,000
Q1 2021

May 04, 2021
BUY
$110.45 - $164.47 $27,612 - $41,117
250 Added 14.29%
2,000 $227,000
Q4 2020

Feb 08, 2021
BUY
$60.78 - $154.03 $106,365 - $269,552
1,750 New
1,750 $257,000

Others Institutions Holding KOD

# of Institutions
103
Shares Held
39.8M
Call Options Held
7.6K
Put Options Held
3.5K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $203M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Compton Capital Management Inc Portfolio

Follow Compton Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email